News
Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions ...
A study, which was published in The New England Journal of Medicine, found that tirzepatide (Zepbound) is more effective for ...
The Indianapolis-based drugmaker sees orforglipron as a potential global breakthrough treatment for weight loss and other ...
Weight-loss drugs are already dropping in price; could they go even lower? - Consumers are now able to pay roughly $500 for ...
The price of weight loss drugs is falling. Wegovy and Zepbound, which both sell for a list price of more than $1,000 a month, have long been out of reach for people without insurance or whose ...
More American teenagers now use the weight-loss drug Wegovy, as doctors and families grow more comfortable with the treatment ...
Today marks the first official agency warning about the possibility of these drugs—specifically Mounjaro—decreasing the ...
The findings presented at a conference in Chicago found a slightly lower risk of obesity-related cancers when adults with ...
As the Food and Drug Administration clamps down on off-brand weight loss medications, Seattle-area residents are stocking up ...
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...
The percentage of adults prescribed a GLP-1 drug like Wegovy or Zepbound jumped almost sevenfold over the past five years, ...
Poison control experts say calls related to GLP-1 weight-loss drugs like Wegovy and Zepbound are rising, with symptoms like ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results